Login to Your Account



Pharma: Other News To Note


Monday, August 27, 2012

The FDA approved an abbreviated new drug application for a generic equivalent to Chadds Ford, Pa.-based Endo Pharmaceuticals Inc.'s Lidoderm (lidocaine topical patch 5 percent) by Watson Laboratories Inc., a subsidiary of Watson Pharmaceuticals Inc., of Parsippany, N.J.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription